Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMO2UKI)

Drug Name

SP-MET-1 Drug Info

Synonyms

S1004A receptor antagonist (cancer), Supratek; SP-MET-X1; Antimetastatic agent (oral, cancer), Supratek; S1004A receptor antagonist (oral, melanoma/breast/colorectal cancer), Supratek

Indication

Disease Entry	ICD 11	Status	REF
Breast cancer	2C60-2C65	Preclinical	[1]

Cross-matching ID

TTD Drug ID: DMO2UKI

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
S100 calcium-binding protein A4 (S100A4)	TTPR5SX	S10A4_HUMAN	Antagonist	[2]

------------------------------------------------------------------------------------

References

1	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800022727)
2	Lost in migration. Nat Biotechnol. 2010 Mar;28(3):214-29.